Molecular Karyotyping for Amniotic Fluid Test sale cost 3740 AED
Thalassemia Beta Trio Prenatal Mutation Detection Test sale cost 4210 AED Thalassemia Beta Trio Prenatal Mutation Detection Test Cost 4,680 د.إ Original price was: 4,680 د.إ.4,210 د.إCurrent price is: 4,210 د.إ.
MM FISH PANEL FISH del11q del13q IgH del17p Test sale cost 2970 AED MM FISH PANEL FISH del11q del13q IgH del17p Test Cost 3,960 د.إ Original price was: 3,960 د.إ.2,970 د.إCurrent price is: 2,970 د.إ.
Sale!

Molecular Karyotyping for Amniotic Fluid Test Cost

Original price was: 4,160 د.إ.Current price is: 3,740 د.إ.

-10%

Molecular karyotyping for amniotic fluid testing is an advanced genetic examination performed at DNA Labs UAE. This state-of-the-art test is designed to detect chromosomal abnormalities in fetuses by analyzing the amniotic fluid, which surrounds the fetus during pregnancy. The process involves extracting fetal DNA from the amniotic fluid and using molecular karyotyping techniques to identify any genetic disorders or chromosomal abnormalities, such as Down syndrome, Edwards syndrome, or Patau syndrome, among others.

The test offers a high level of accuracy and provides a comprehensive analysis of the chromosomes, going beyond the capabilities of traditional karyotyping methods. It is particularly recommended for pregnancies considered at higher risk for genetic abnormalities. The cost of the molecular karyotyping for amniotic fluid test at DNA Labs UAE is 3740 AED, reflecting the sophisticated technology and expertise involved in conducting this detailed genetic analysis. This test represents a crucial step for expecting parents in understanding and preparing for the health needs of their unborn child.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Molecular Karyotyping for Amniotic Fluid Test

Cost: AED 3740.0

Symptoms, Diagnosis, and Test Details

The Molecular Karyotyping for Amniotic Fluid Test is a diagnostic test that can be performed on amniotic fluid samples to detect chromosomal abnormalities in the fetus. This test, also known as chromosomal microarray analysis (CMA), is conducted by extracting and analyzing DNA from the amniotic fluid cells. The DNA is then amplified and labeled with fluorescent dyes before being hybridized to a DNA microarray.

The DNA microarray contains thousands of small DNA fragments representing different regions of the chromosomes. The microarray is scanned, and the fluorescence intensity of each spot on the microarray is measured. By comparing the fluorescence intensity of the sample DNA to a reference DNA, any differences in DNA copy number can be detected. This technique can identify copy number variations (CNVs), which are deletions or duplications of DNA segments.

Molecular karyotyping can detect a wide range of chromosomal abnormalities, including aneuploidies (such as trisomy 21, which causes Down syndrome), microdeletions/microduplications, and other structural chromosomal abnormalities. It has a higher resolution compared to traditional karyotyping, which can only detect larger chromosomal abnormalities.

This test is typically recommended when there are indications of a potential chromosomal abnormality in the fetus, such as abnormal ultrasound findings or a family history of genetic disorders. It can also be performed if the mother is of advanced maternal age, as the risk of chromosomal abnormalities increases with age.

Test Information and Report Delivery

The Molecular Karyotyping for Amniotic Fluid Test is performed using cell culture and falls under the category of Genetics. The test is conducted by a Gynecologist in the Test Department. The sample condition required for the test is amniotic fluid.

The report for the test is usually delivered within 7-9 days. It is important to note that this test is a safe procedure, but there is a small risk of complications, such as infection or leakage of amniotic fluid.

Conclusion

Molecular Karyotyping for Amniotic Fluid Testing is a valuable diagnostic tool that can provide important information about the genetic health of the fetus. It can help parents make informed decisions about their pregnancy and prepare for any potential medical or developmental needs of the child.

Test Name Molecular Karyotyping for Amniotic Fluid Test
Components
Price 3740.0 AED
Sample Condition
Report Delivery 7-9 days
Method Cell culture
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information
Test Details

Molecular karyotyping, also known as chromosomal microarray analysis (CMA), is a diagnostic test that can be performed on amniotic fluid samples. This test is used to detect chromosomal abnormalities in the fetus.

During a molecular karyotyping test, DNA from the amniotic fluid cells is extracted and analyzed. The DNA is then amplified and labeled with fluorescent dyes. The labeled DNA is then hybridized to a DNA microarray, which contains thousands of small DNA fragments representing different regions of the chromosomes.

The microarray is scanned, and the fluorescence intensity of each spot on the microarray is measured. By comparing the fluorescence intensity of the sample DNA to a reference DNA, any differences in DNA copy number can be detected. Copy number variations (CNVs), which are deletions or duplications of DNA segments, can be identified using this technique.

Molecular karyotyping can detect a wide range of chromosomal abnormalities, including aneuploidies (such as trisomy 21, which causes Down syndrome), microdeletions/microduplications, and other structural chromosomal abnormalities. It has a higher resolution compared to traditional karyotyping, which can only detect larger chromosomal abnormalities.

This test is typically recommended when there are indications of a potential chromosomal abnormality in the fetus, such as abnormal ultrasound findings or a family history of genetic disorders. It can also be performed if the mother is of advanced maternal age, as the risk of chromosomal abnormalities increases with age.

Molecular karyotyping for amniotic fluid testing is a safe procedure, but there is a small risk of complications, such as infection or leakage of amniotic fluid. The test is usually performed between 15 and 20 weeks of pregnancy, and the results are typically available within two weeks.

Overall, molecular karyotyping for amniotic fluid testing is a valuable diagnostic tool that can provide important information about the genetic health of the fetus. It can help parents make informed decisions about their pregnancy and prepare for any potential medical or developmental needs of the child.

SKU: TEST-4685 Category:

Related products